0001493152-23-000191.txt : 20230103
0001493152-23-000191.hdr.sgml : 20230103
20230103215317
ACCESSION NUMBER: 0001493152-23-000191
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230102
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOLL ANDREW R.
CENTRAL INDEX KEY: 0001542150
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 23504236
MAIL ADDRESS:
STREET 1: 437 S HWY 101
STREET 2: STE 209
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER NAME:
FORMER CONFORMED NAME: Boll Andrew
DATE OF NAME CHANGE: 20120210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW HEALTH, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
FORMER COMPANY:
FORMER CONFORMED NAME: Bywater Resources, Inc
DATE OF NAME CHANGE: 20060421
4
1
ownership.xml
X0306
4
2023-01-02
0
0001360214
HARROW HEALTH, INC.
HROW
0001542150
BOLL ANDREW R.
C/O HARROW HEALTH, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
0
1
0
0
Chief Financial Officer
Common Stock
2023-01-02
4
M
0
23000
A
278063
D
Common Stock
2023-01-02
4
F
0
9602
14.76
D
268461
D
Restricted Stock Unit
0
2023-01-02
4
M
0
23000
0
D
Common Stock
23000
0
D
The listed Acquired (as described in the table above) 23,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Boll under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs vested in full on January 2, 2023, the third-year anniversary of the grant of the same, and settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 9,602 shares of Harrow common stock were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld from the same aforementioned 23,000 share RSU issuance, by the Company, for payroll tax purposes only.
/s/ Andrew R. Boll
2023-01-03